The triterpenoid fraction from Trichosanthes dioica root exhibits antiproliferative activity against Ehrlich ascites carcinoma in albino mice: Involvement of possible antioxidant role

Journal of Experimental Therapeutics and Oncology

Volumn 9, Issue 4, 2012, Pages 281-290

  Bhattacharya, Sanjib ^a   Haldar, Pallab Kanti ^b  

^a Bengal School of Technology   (India)

^b JADAVPUR UNIVERSITY   (India)

Author keywords

Antiproliferative; Cucurbitacin; Glutathione; Glutathione S transferase; Lipid peroxidation

Indexed keywords

ANTINEOPLASTIC AGENT; CATALASE; FLUOROURACIL; GLUTATHIONE; GLUTATHIONE TRANSFERASE; SUPEROXIDE DISMUTASE; TRICHOSANTHES DIOICA EXTRACT; TRICHOSANTHES EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CELL VOLUME; CONTROLLED STUDY; DRUG EFFICACY; EHRLICH ASCITES TUMOR; IN VITRO STUDY; LIPID PEROXIDATION; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; PHARMACOLOGICAL PARAMETERS; PLANT ROOT; PRIORITY JOURNAL; THERAPY EFFECT; TRICHOSANTHES; TRICHOSANTHES DIOICA; TUMOR CELL; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; ASCITES; CARCINOMA, EHRLICH TUMOR; CATALASE; CELL PROLIFERATION; GLUTATHIONE; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MICE; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS; PLANT ROOTS; SUPEROXIDE DISMUTASE; TRICHOSANTHES; TUMOR BURDEN;

EID: 84860646602     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Evans WC. Trease and Evans Pharmacognosy. New Delhi: Reed Elsevier India Pvt. Ltd. 2002.
2. Stewart BS, Kleihues P. Cancers of female reproductive tract. In: World Cancer Report. Lyon, France: World Health Organization, International Agency for Research in Cancer, IARC Press. 2003.
3. Mascarenhas M. Structure-activity characterization, a quick method to screen mushrooms for the presence of antitumor glucans. Mushroom Res 3: 77-80, 1994.
4. Nitha B, Meera CR, Janardhanan KK. Antitumor activity of ethanolic extract of Lentinus dicholamellatus. Amala Res Bull 25: 165-168, 2005.
5. da-Rocha AB, Lopes RM, Schwartsmann G. Natural products in anticancer therapy. Curr Opin Pharmacol 1: 364-369, 2001. (Pubitemid 33585985)
6. Kirtikar KR, Basu BD. Indian Medicinal Plants. New Delhi: Bishen Singh Mahendra Pal Singh. 1935.
7. Anonymous. The Wealth of India: Raw Materials. New Delhi: Publication and Information Directorate, CSIR. 1976.
8. Nadkarni KM. Indian Materia Medica. Bombay: Popular Prakashan. 1976.
9. Sharma PC, Yelne MB, Dennis TJ. Database on Medicinal Plants Used in Ayurveda. New Delhi: Central Council for Research in Ayurveda and Siddha. 2002.
10. Sharma G, Pant MC. Preliminary observations on serum biochemical parameters of albino rabbits fed on seeds of Trichosanthes dioica (Roxb). Indian J Med Res 87: 398-400, 1988.
11. Sharma G, Pant, MC. Effect of raw deseeded fruit powder of Trichosanthes dioica (Roxb.) on blood sugar, serum cholesterol, high density lipoprotein, phospholipid and triglyceride levels in the normal albino rabbits. Indian J Physiol Pharmacol 32: 161-163, 1988.
12. Sharma G, Pant MC. Effect of feeding Trichosanthes dioica (Parval) whole fruits on blood glucose, serum triglycerides, phospholipid, cholesterol and high density lipoproteincholesterol levels in the normal albino rabbits. Curr Sci 57: 1085-1087, 1988.
13. Sharma G, Pandey DN, Pant MC. Biochemical evaluation of feeding Trichosanthes dioica seeds in normal and mild diabetic human subjects in relation to lipid profile. Indian J Physiol Pharmacol 34: 146-148, 1990. (Pubitemid 20331854)
14. Kabir S. The novel peptide composition of the seeds of Trichosanthes dioica Roxb. Cytobios 103: 121-131, 2000.
15. Sultan NA, Kenoth R, Swamy MJ. Purification, physicochemical characterization, saccharide specificity, and chemical modification of a Gal/GalNAc specific lectin from the seeds of Trichosanthes dioica. Arch Biochem Biophys 432: 212-221, 2004. (Pubitemid 39480731)
16. Sultan NA, Swamy MJ. Fluorescence quenching and time-resolved fluorescence studies on Trichosanthes dioica seed lectin. J Photochem Photobiol 80: 93-100, 2005. (Pubitemid 40984407)
17. Sharmila BG, Kumar G, Rajasekara PM. Cholesterol lowering activity of the aqueous fruit extract of Trichosanthes dioica Roxb. in normal and streptozotocin diabetic rats. J Clin Diagnostic Res 1: 561-569, 2007.
18. Ghaisas MM, Tanwar MB, Ninave PB, Navghare VV, Takawale AR, Zope VS, Deshpande AD. Hepatoprotective activity of aqueous and ethanolic extract of Trichosanthes dioica Roxb. in ferrous sulphate-induced liver injury. Pharmacologyonline 4: 127-135, 2008.
19. Rai PK, Jaiswal D, Rai DK, Sharma B, Watal, G. Effect of water extract of Trichosanthes dioica fruits in streptozotocin induced diabetic rats. Indian J Clin Biochem 23: 387-390, 2008.
20. Rai PK, Jaiswal D, Diwakar S, Watal G. Antihyperglycemic profile of Trichosanthes dioica seeds in experimental models. Pharm Biol 46: 360-365, 2008. (Pubitemid 351534437)
21. Bhattacharya S, Haldar PK, Ghosh AK. In vitro effects of Trichosanthes dioica leaves on annelids and nematodes. Pharmacologyonline, 5: 242-248, 2009.
22. Bhattacharya S, Haldar PK, Ghosh, AK. Paralytic and lethal effects of Trichosanthes dioica root extracts in experimental worms. Pharm Biol 48: 960-965, 2010.
23. Bhattacharya S, Haldar PK. Antibacterial activity of Trichosanthes dioica root. Global J Pharmacol 4: 122-126, 2010.
24. Bhattacharya S, Haldar PK. Evaluation of in vitro cytotoxic effect of Trichosanthes dioica root. Pharmacognosy Res 2: 355-358, 2010.
25. Harborne JB. Phytochemical Methods, a Guide to Modern Techniques of Plant Analysis. New Delhi: Springer (India) Pvt. Ltd. 1998.
26. Wagner H, Bladt B. Plant Drug Analysis, A Thin Layer Chroatography Atlas. Berlin Hiedelberg: Springer Verlag. 1996.
27. Sur P, Ganguly DK. Tea plant root extract is an antineoplastic agent. Planta Med 60: 106-109, 1994. (Pubitemid 24120889)
28. Haldar PK, Kar B, Bala A, Bhattacharya S, Mazumder UK. Antitumor activity of Sansevieria roxburghiana rhizome against Ehrlich ascites carcinoma in mice. Pharm Biol 48: 1337-1343, 2010.
29. D'Armour FE, Blood FR, Belden DA. The Manual for Laboratory Works in Mammalian Physiology. Illinois, Chicago: The University of Chicago Press. 1965.
30. Wintrobe MM, Lee GR, Boggs DR, Bithel TC, Athens JW, Foerster J. Clinical Hematology. Philadelphia: Les & Febiger. 1961.
31. Dacie JV, Lewis SM. Practical Hematology. London: J & A, Churchill Ltd. 1958.
32. Ohkawa H, Onishi N, Yagi K. Assay for lipid peroxidation in animal tissue by thiobarbituric acid reaction. Anal Biochem 95: 351-358, 1979. (Pubitemid 9194347)
33. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 82: 70-77, 1959.
34. Habig WH, Pabst MJ, Jakoby WB. Glutathione-S-transferase: The first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130-7139, 1974.
35. Lowry OH, Rosebrough NJ, Farr AL, Randall RI. Protein measurement with the folin-phenol reagent. J Biol Chem 193: 265-272, 1951.
36. Kakkar P, Das B, Vishwanathm PN. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys 21: 130-132, 1984. (Pubitemid 15207169)
37. Sinha KA. Colorimetric assay of catalase. Annal Biochem 47: 389-394, 1972.
38. Chen L, Watkins JK. Evidences against the presence of 112 histocompatibility antigens in Ehrlich ascites tumor cells. Nature 225: 734-735, 1970.
39. Segura JA, Barbero LG, Marquez J. Ehrlich ascites tumor unbalances splenic cell populations and reduced responsiveness of T cells to Staphylococcus aureus enterotoxin B Stimulation. Immunomol Lett 74: 111-115, 2000.
40. Gupta M, Mazumder UK, Kumar RS, Sivakumar T, Vamsi MLM. Antitumor activity and antioxidant status of Caesalpinia bonducella against Ehrlich ascites carcinoma in Swiss albino mice. J Pharmacol Sci 94: 177-184, 2004. (Pubitemid 38405132)
41. Fastaia J, Dumont A. Pathogenesis of ascitis in mice with peritoneal carcinomatosis. J Natl Cancer Inst 56: 547-549, 1976.
42. Clarkson D, Burchneal JH. Preliminary screening of antineoplastic drugs. Prog Clin Cancer 1: 625-629, 1965.
43. Andreani AG, Galatulas SI. Potential antitumor agents. IX: Synthesis and antitumor activity of two analogues of ketocaine. J Pharm Sci 72: 814-819, 1983.
44. Price VE, Greenfield RE. Anemia in cancer. In: Grenstein JP, Haddaw A. eds. Advances in Cancer Research. New York: Academic Press, 199-200, 1958.
45. Hogland HC. Hematological complications of cancer chemotherapy. Semin Oncol 9: 95-102, 1982.
46. Gupta M, Mazumder UK, Kumar RS, Kumar TS. Antitumor activity and antioxidant role of Bauhinia racemosa against Ehrlich ascites carcinoma in Swiss albino mice. Acta Pharmacol Sin 25: 1070-1076, 2004. (Pubitemid 39071116)
47. Pahl H, Baeuerle P. Oxygen and the control of gene expression. Bio-Essays 16: 497-502. 1994.
48. Oberley TD. Oxidative damage and cancer. Am J Pathol 160: 403-408, 2002. (Pubitemid 34160315)
49. Balasubramaniyan N, Subramanian S, Govindasamy, S. Status of antioxidant systems in human carcinoma of uterine cervix. Cancer Lett 87: 187-192, 1994.
50. Casado A, Torre R, Lopez-Fernandez M, Carrascosa D, Casado M, Ramirez M. Superoxide dismutase and catalase blood levels in patients with malignant diseases. Cancer Lett 93: 187-192, 1995.
51. Yellin S, Davidson B, Pinto J, Sacks P, Qiao C, Schantz S. Relationship of glutathione and glutathione-S-transferase to cisplatin sensitivity in human head and neck squamous carcinoma cell lines. Cancer Lett 85: 223-232, 1994. (Pubitemid 24302964)
52. Sharma R, Singhal S, Srivastava S, Bajpai K, Frankel E, Awasthi S. Glutathione and glutathione linked enzymes in human small lung cancer cell lines. Cancer Lett 75: 111-119, 1993. (Pubitemid 24014534)
53. Baumgartner WA, Hill VA, Wright ET. Antioxidant effects in development of Ehrlich ascites carcinoma. Am J Clin Nutr 31: 457-465, 1978. (Pubitemid 8300940)
54. Yoshikawa T, Tanaka H, Yoshida H, Sato O, Sugino N, Kondo M. Adjuvant arthritis and lipid peroxidation protection protection by superoxide dismutase. Lipid Peroxide Res 7: 108-112, 1983.
55. Yagi K. Lipid peroxides and human diseases. Chem Physiol Lip 45: 337-351, 1991. (Pubitemid 17152340)
56. Neilson F, Mikkelson BB, Nielsen JB, Andersen HR, Grandjean P. Plasma malondialdehyde as biomarker for oxidative stress, reference interval and effects of life-style factors. Clin Chemist 47: 1209-1214, 1997. (Pubitemid 27297265)
57. Arias IM, Jakoby B. Glutathione: Metabolisms and Functions. New York: Raven Press. 1976.
58. Meister A, Anderson ME. Glutathione. Annu Rev Biochem 52: 711-760, 1983. (Pubitemid 13030692)
59. Gmunder H, Droge W. Differential effects of glutathione depletion on T-cell subsets. Cell Immunol 138: 229-237, 1991.
60. Devi KN, Reddy CC, Raveendra A, Thyagaraju K. Effect of β-methylcholanthrene on glutathione S-transferases of rat testis. Curr Sci 82: 1282-1287, 2002. (Pubitemid 135694178)
61. Mulder TPJ, Manni JJ, Roelof HMJ, Peters WHM, Wiersma A. Glutathione-S-transferase and glutathione in human head and neck cancer. Carcinogenesis 16: 619-624, 1995.
62. Coursin DB, Cihla HP, Sempf JM, Oberley TD, Oberley LW. An immunohistochemical analysis of antioxidant and glutathione S-transferase enzyme levels in normal and neoplastic human lung. Histol Histopathol 11: 851-860, 1996. (Pubitemid 26364206)
63. Jiau-Jian L, Larry WO. Over expression of manganese-containing superoxide dismutase confers resistance to the cytotoxicity of tumor necrosis factor α and/or hyperthermia. Cancer Res 57: 1991-1998, 1977.
64. Oberley TD, Oberley LW. Antioxidant enzyme levels in cancer. Histol Histopathol 12: 525-535, 1997. (Pubitemid 27240324)
65. Marklund SL, Westman NG, Lundgren E, Roos G. Copper and zinc containing superoxide dismutase, manganese containing superoxide dismutase, catalsae amd glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues. Cancer Res 42: 1955-1961, 1982. (Pubitemid 12103398)
66. Miro M. Cucurbitacins and their pharmacological effects. Photother Res 9: 159-168, 2006.